eF-site ID 5c0f-B PDB Code 5c0f Chain B click to enlarge Title HLA-A02 carrying RQWGPDPAAV Classification IMMUNE SYSTEM Compound HLA class I histocompatibility antigen, A-2 alpha chain Source Homo sapiens (Human) (5C0F) Sequence B:  MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDL LKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYA CRVNHVTLSQPKIVKWDRDM Description Functional site 1) chain B residue 57 type sequence S description binding site for residue EDO A 302 source : AC2 2) chain B residue 58 type sequence K description binding site for residue EDO A 302 source : AC2 3) chain B residue 60 type sequence W description binding site for residue EDO A 302 source : AC2 4) chain B residue 14 type sequence P description binding site for residue EDO A 304 source : AC4 5) chain B residue 12 type sequence R description binding site for residue MES A 311 source : AD2 6) chain B residue 14 type sequence P description binding site for residue MES A 311 source : AD2 7) chain B residue 0 type sequence M description binding site for residue SO4 A 314 source : AD5 8) chain B residue 11 type sequence S description binding site for residue EDO B 301 source : AD8 9) chain B residue 13 type sequence H description binding site for residue EDO B 301 source : AD8 10) chain B residue 14 type sequence P description binding site for residue EDO B 301 source : AD8 11) chain B residue 33 type sequence S description binding site for residue EDO B 302 source : AD9 12) chain B residue 34 type sequence D description binding site for residue EDO B 302 source : AD9 13) chain B residue 8 type sequence Q description binding site for residue EDO B 303 source : AE1 14) chain B residue 9 type sequence V description binding site for residue EDO B 303 source : AE1 15) chain B residue 94 type sequence K description binding site for residue EDO B 303 source : AE1 16) chain B residue 96 type sequence D description binding site for residue EDO B 303 source : AE1 17) chain B residue 95 type sequence W description binding site for residue EDO B 304 source : AE2 18) chain B residue 97 type sequence R description binding site for residue EDO B 304 source : AE2 19) chain B residue 52 type sequence S description binding site for residue EDO B 305 source : AE3 20) chain B residue 63 type sequence Y description binding site for residue EDO B 305 source : AE3 21) chain B residue 36 type sequence E description binding site for residue EDO B 306 source : AE4 22) chain B residue 83 type sequence N description binding site for residue EDO B 306 source : AE4 23) chain B residue 84 type sequence H description binding site for residue EDO B 306 source : AE4 24) chain B residue 1 type sequence I description binding site for residue EDO B 307 source : AE5 25) chain B residue 2 type sequence Q description binding site for residue EDO B 307 source : AE5 26) chain B residue 32 type sequence P description binding site for residue EDO B 307 source : AE5 27) chain B residue 20 type sequence S description binding site for residue EDO B 308 source : AE6 28) chain B residue 21 type sequence N description binding site for residue EDO B 308 source : AE6 29) chain B residue 22 type sequence F description binding site for residue EDO B 308 source : AE6 30) chain B residue 69 type sequence E description binding site for residue EDO B 308 source : AE6 31) chain B residue 51 type sequence H description binding site for residue EDO B 309 source : AE7 32) chain B residue 52 type sequence S description binding site for residue EDO B 309 source : AE7 33) chain B residue 53 type sequence D description binding site for residue EDO B 309 source : AE7 34) chain B residue 54 type sequence L description binding site for residue EDO B 309 source : AE7 35) chain B residue 2 type MOD_RES sequence Q description Pyrrolidone carboxylic acid; in form pI 5.3 => ECO:0000269|PubMed:7554280 source Swiss-Prot : SWS_FT_FI1 36) chain B residue 1 type CARBOHYD sequence I description N-linked (Glc) (glycation) isoleucine; in hemodialysis-associated amyloidosis => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI2 37) chain B residue 19 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 38) chain B residue 41 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 39) chain B residue 48 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 40) chain B residue 58 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 41) chain B residue 91 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 42) chain B residue 94 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 43) chain B residue 78-84 type prosite sequence YACRVNH description IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YACRVNH source prosite : PS00290

Display surface Download Links